{ "cells": [ { "cell_type": "code", "execution_count": 1, "metadata": {}, "outputs": [], "source": [ "import pandas as pd" ] }, { "cell_type": "code", "execution_count": 8, "metadata": {}, "outputs": [], "source": [ "detaildf = pd.read_csv('../ClinicalTrialCSV/JRCT20241128Cancer.csv', index_col=0)\n", "targetdf = pd.read_csv('../ClinicalTrialCSV/20241128Target.csv',index_col=0)" ] }, { "cell_type": "code", "execution_count": 9, "metadata": {}, "outputs": [ { "data": { "text/html": [ "
\n", "\n", "\n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", "
JRCT IDTarget
0jRCT1032240511がん患者の疼痛
1jRCT1032240506卵巣がん
2jRCT1042240125膵嚢胞、慢性膵炎、家族性膵がん及び遺伝性膵がん家族歴を有する症例、糖尿病症例(新規発症・急性...
3jRCT1052240186肺がん
4jRCT1030240477固形がん
.........
231jRCT2080224549進行性悪性黒色腫
232jRCTs051180046乳がん
233jRCT2091220364ALK遺伝子異常を有する希少がん
234jRCT2080223823Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん
235jRCT1090220224下腹部消化器がん
\n", "

236 rows × 2 columns

\n", "
" ], "text/plain": [ " JRCT ID Target\n", "0 jRCT1032240511 がん患者の疼痛\n", "1 jRCT1032240506 卵巣がん\n", "2 jRCT1042240125 膵嚢胞、慢性膵炎、家族性膵がん及び遺伝性膵がん家族歴を有する症例、糖尿病症例(新規発症・急性...\n", "3 jRCT1052240186 肺がん\n", "4 jRCT1030240477 固形がん\n", ".. ... ...\n", "231 jRCT2080224549 進行性悪性黒色腫\n", "232 jRCTs051180046 乳がん\n", "233 jRCT2091220364 ALK遺伝子異常を有する希少がん\n", "234 jRCT2080223823 Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん\n", "235 jRCT1090220224 下腹部消化器がん \n", "\n", "[236 rows x 2 columns]" ] }, "execution_count": 9, "metadata": {}, "output_type": "execute_result" } ], "source": [ "targetdf" ] }, { "cell_type": "code", "execution_count": 10, "metadata": {}, "outputs": [], "source": [ "merged_df = pd.merge(targetdf, detaildf, on=\"JRCT ID\", how=\"inner\")" ] }, { "cell_type": "code", "execution_count": 11, "metadata": {}, "outputs": [ { "data": { "text/html": [ "
\n", "\n", "\n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", "
JRCT IDTargetTitle研究・治験の目的試験の種類無作為化盲検化対照割付け研究目的...assignmentpurposeInclusion CriteriaExclusion CriteriaAge MinimumAge MaximumGenderDiscontinuation CriteriaKeywordIntervention(s)
0jRCT1032240511がん患者の疼痛進行がん患者の痛みに対する交番磁界治療器の至適な治療時間の条件に関する多施設共同研究交番磁界治療器を用いた自宅での疼痛治療について、進行がん患者が治療の継続が可能と考える治療時...介入研究単一群非盲検非対照単群比較その他...single assignmentother1. Age 18 years or older on the day of consent...1. There is a skin disorder in the painful are...18age old overNo limitBothNaNNaNFour pads of the alternating magnetic field th...
1jRCT1032240506卵巣がん卵巣腫瘍手術での術中低圧換気介入による術中出血量に及ぼす影響:ランダム化比較試験卵巣悪性腫瘍手術は高侵襲な手術であり輸血率の高い手術である。一方で輸血により癌の予後が悪化す...介入研究無作為化比較単盲検実薬(治療)対照並行群間比較治療...parallel assignmenttreatment purposePatients undergoing ovarian cancer surgery at ...1.Minors\\n\\r\\n2.Emergency surgery\\n\\r\\n3.Patie...18age old over100age old notFemaleNaNNaNLow-pressure ventilation and low venous pressu...
2jRCT1042240125膵嚢胞、慢性膵炎、家族性膵がん及び遺伝性膵がん家族歴を有する症例、糖尿病症例(新規発症・急性...Liquid Biopsyによる膵がん早期診断法の開発本研究では、膵がん高危険群である膵のう胞性病変等を対象にサーベイランスプログラムを立ち上げ、...観察研究単一群非盲検非対照単群比較診断...single assignmentdiagnostic purpose1. Cases diagnosed as high-risk group for panc...1. Post-Pancreatic Surgery Cases\\n\\r\\n2. Cases...20age old overNo limitBothNaNNaNNaN
3jRCT1052240186肺がんトリモーダルプレハビリテーションが周術期の睡眠に及ぼす影響の検討:ランダム化比較試験術前の介入により、介入群の方が対照群に比べて入院直後の睡眠効率が良いかどうかを検討すること介入研究無作為化比較非盲検無治療対照/標準治療対照単群比較予防...single assignmentprevention purpose1) Patients aged 20 and over \\n\\r\\n2) Lung can...1) Patients who do not agree \\n\\r\\n2) Patients...20age old overNo limitBothNaNMalignancyIntervention for the Experimental Group:\\n\\r\\n...
4jRCT1030240477固形がんプレシジョンオンコロジーを加速するためのスコアリングシステムを開発する研究本研究の目的は、がん遺伝子パネル検査後、国立がん研究センター中央病院を受診した患者のデータを...観察研究NaNNaNNaNNaNその他...NaNother1. Physicians who performed cancer gene panel ...Physicians deemed inappropriate by the Princip...No limitNo limitBothNaNGenotype-matched trialNaN
..................................................................
231jRCT2080224549進行性悪性黒色腫進行性悪性黒色腫患者を対象としたGEN0101の皮内投与と、ペムブロリズマブ(抗PD-1抗体...NaN介入研究NaNNaNNaNNaNNaN...NaNNaNNaNNaNNaNNaN<p>Both</p>NaNNaNinvestigational material(s)<br>\\nGeneric name ...
232jRCTs051180046乳がん造影CT及び造影MRIを用いた乳がんセンチネルリンパ節転移診断による腋窩手術回避に関する研究原発乳がん患者に対して、造影CTとMRIを用いた転移診断により、転移陰性例に腋窩手術を安全に...介入研究単一群非盲検ヒストリカルコントロール単群比較治療...single assignmenttreatment purpose1.T1-2 primary breast cancer\\n\\r\\n2.Clinically...1.Contraindication of contrast agents\\n\\r\\n2.P...18age old overNo limitBothNaNBreast cancerIdentify the sentinel node by contrast-enhance...
233jRCT2091220364ALK遺伝子異常を有する希少がんALK遺伝子異常を有する希少がんに対するアレクチニブの医師主導治験NaNNaNNaN非盲検無対照NaNNaN...NaNNaNNaNNaNAge 7Month Week Day Hour overAge Month Week Day Hour No limitBothNaNNaNIntervention type:DRUG\\n\\nName of intervention...
234jRCT2080223823Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん固形がん患者を対象としたE7130 の臨床第1相試験NaN介入研究NaNNaNNaNNaNNaN...NaNNaNNaNNaNNaNNaN<p>Both</p>NaNNaNinvestigational material(s)<br>\\nGeneric name ...
235jRCT1090220224下腹部消化器がん体幹部神経ブロック後のレボブピバカインの血中濃度の変化NaNNaNNaN非盲検無対照NaNNaN...NaNNaNNaNNaN20Age Month Week Day Hour overAge Month Week Day Hour No limitBothNaNNaNIntervention type:\\n\\nName of intervention:\\n\\...
\n", "

236 rows × 33 columns

\n", "
" ], "text/plain": [ " JRCT ID Target \\\n", "0 jRCT1032240511 がん患者の疼痛 \n", "1 jRCT1032240506 卵巣がん \n", "2 jRCT1042240125 膵嚢胞、慢性膵炎、家族性膵がん及び遺伝性膵がん家族歴を有する症例、糖尿病症例(新規発症・急性... \n", "3 jRCT1052240186 肺がん \n", "4 jRCT1030240477 固形がん \n", ".. ... ... \n", "231 jRCT2080224549 進行性悪性黒色腫 \n", "232 jRCTs051180046 乳がん \n", "233 jRCT2091220364 ALK遺伝子異常を有する希少がん \n", "234 jRCT2080223823 Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん \n", "235 jRCT1090220224 下腹部消化器がん \n", "\n", " Title \\\n", "0 進行がん患者の痛みに対する交番磁界治療器の至適な治療時間の条件に関する多施設共同研究 \n", "1 卵巣腫瘍手術での術中低圧換気介入による術中出血量に及ぼす影響:ランダム化比較試験 \n", "2 Liquid Biopsyによる膵がん早期診断法の開発 \n", "3 トリモーダルプレハビリテーションが周術期の睡眠に及ぼす影響の検討:ランダム化比較試験 \n", "4 プレシジョンオンコロジーを加速するためのスコアリングシステムを開発する研究 \n", ".. ... \n", "231 進行性悪性黒色腫患者を対象としたGEN0101の皮内投与と、ペムブロリズマブ(抗PD-1抗体... \n", "232 造影CT及び造影MRIを用いた乳がんセンチネルリンパ節転移診断による腋窩手術回避に関する研究 \n", "233 ALK遺伝子異常を有する希少がんに対するアレクチニブの医師主導治験 \n", "234 固形がん患者を対象としたE7130 の臨床第1相試験 \n", "235 体幹部神経ブロック後のレボブピバカインの血中濃度の変化 \n", "\n", " 研究・治験の目的 試験の種類 無作為化 盲検化 \\\n", "0 交番磁界治療器を用いた自宅での疼痛治療について、進行がん患者が治療の継続が可能と考える治療時... 介入研究 単一群 非盲検 \n", "1 卵巣悪性腫瘍手術は高侵襲な手術であり輸血率の高い手術である。一方で輸血により癌の予後が悪化す... 介入研究 無作為化比較 単盲検 \n", "2 本研究では、膵がん高危険群である膵のう胞性病変等を対象にサーベイランスプログラムを立ち上げ、... 観察研究 単一群 非盲検 \n", "3 術前の介入により、介入群の方が対照群に比べて入院直後の睡眠効率が良いかどうかを検討すること 介入研究 無作為化比較 非盲検 \n", "4 本研究の目的は、がん遺伝子パネル検査後、国立がん研究センター中央病院を受診した患者のデータを... 観察研究 NaN NaN \n", ".. ... ... ... ... \n", "231 NaN 介入研究 NaN NaN \n", "232 原発乳がん患者に対して、造影CTとMRIを用いた転移診断により、転移陰性例に腋窩手術を安全に... 介入研究 単一群 非盲検 \n", "233 NaN NaN NaN 非盲検 \n", "234 NaN 介入研究 NaN NaN \n", "235 NaN NaN NaN 非盲検 \n", "\n", " 対照 割付け 研究目的 ... assignment purpose \\\n", "0 非対照 単群比較 その他 ... single assignment other \n", "1 実薬(治療)対照 並行群間比較 治療 ... parallel assignment treatment purpose \n", "2 非対照 単群比較 診断 ... single assignment diagnostic purpose \n", "3 無治療対照/標準治療対照 単群比較 予防 ... single assignment prevention purpose \n", "4 NaN NaN その他 ... NaN other \n", ".. ... ... ... ... ... ... \n", "231 NaN NaN NaN ... NaN NaN \n", "232 ヒストリカルコントロール 単群比較 治療 ... single assignment treatment purpose \n", "233 無対照 NaN NaN ... NaN NaN \n", "234 NaN NaN NaN ... NaN NaN \n", "235 無対照 NaN NaN ... NaN NaN \n", "\n", " Inclusion Criteria \\\n", "0 1. Age 18 years or older on the day of consent... \n", "1 Patients undergoing ovarian cancer surgery at ... \n", "2 1. Cases diagnosed as high-risk group for panc... \n", "3 1) Patients aged 20 and over \\n\\r\\n2) Lung can... \n", "4 1. Physicians who performed cancer gene panel ... \n", ".. ... \n", "231 NaN \n", "232 1.T1-2 primary breast cancer\\n\\r\\n2.Clinically... \n", "233 NaN \n", "234 NaN \n", "235 NaN \n", "\n", " Exclusion Criteria \\\n", "0 1. There is a skin disorder in the painful are... \n", "1 1.Minors\\n\\r\\n2.Emergency surgery\\n\\r\\n3.Patie... \n", "2 1. Post-Pancreatic Surgery Cases\\n\\r\\n2. Cases... \n", "3 1) Patients who do not agree \\n\\r\\n2) Patients... \n", "4 Physicians deemed inappropriate by the Princip... \n", ".. ... \n", "231 NaN \n", "232 1.Contraindication of contrast agents\\n\\r\\n2.P... \n", "233 NaN \n", "234 NaN \n", "235 NaN \n", "\n", " Age Minimum Age Maximum \\\n", "0 18age old over No limit \n", "1 18age old over 100age old not \n", "2 20age old over No limit \n", "3 20age old over No limit \n", "4 No limit No limit \n", ".. ... ... \n", "231 NaN NaN \n", "232 18age old over No limit \n", "233 Age 7Month Week Day Hour over Age Month Week Day Hour No limit \n", "234 NaN NaN \n", "235 20Age Month Week Day Hour over Age Month Week Day Hour No limit \n", "\n", " Gender Discontinuation Criteria Keyword \\\n", "0 Both NaN NaN \n", "1 Female NaN NaN \n", "2 Both NaN NaN \n", "3 Both NaN Malignancy \n", "4 Both NaN Genotype-matched trial \n", ".. ... ... ... \n", "231

Both

NaN NaN \n", "232 Both NaN Breast cancer \n", "233 Both NaN NaN \n", "234

Both

NaN NaN \n", "235 Both NaN NaN \n", "\n", " Intervention(s) \n", "0 Four pads of the alternating magnetic field th... \n", "1 Low-pressure ventilation and low venous pressu... \n", "2 NaN \n", "3 Intervention for the Experimental Group:\\n\\r\\n... \n", "4 NaN \n", ".. ... \n", "231 investigational material(s)
\\nGeneric name ... \n", "232 Identify the sentinel node by contrast-enhance... \n", "233 Intervention type:DRUG\\n\\nName of intervention... \n", "234 investigational material(s)
\\nGeneric name ... \n", "235 Intervention type:\\n\\nName of intervention:\\n\\... \n", "\n", "[236 rows x 33 columns]" ] }, "execution_count": 11, "metadata": {}, "output_type": "execute_result" } ], "source": [ "merged_df" ] }, { "cell_type": "code", "execution_count": 12, "metadata": {}, "outputs": [ { "data": { "text/html": [ "
\n", "\n", "\n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", " \n", "
JRCT IDTarget
0jRCT1032240511がん患者の疼痛
1jRCT1032240506卵巣がん
2jRCT1042240125膵嚢胞、慢性膵炎、家族性膵がん及び遺伝性膵がん家族歴を有する症例、糖尿病症例(新規発症・急性...
3jRCT1052240186肺がん
4jRCT1030240477固形がん
.........
231jRCT2080224549進行性悪性黒色腫
232jRCTs051180046乳がん
233jRCT2091220364ALK遺伝子異常を有する希少がん
234jRCT2080223823Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん
235jRCT1090220224下腹部消化器がん
\n", "

236 rows × 2 columns

\n", "
" ], "text/plain": [ " JRCT ID Target\n", "0 jRCT1032240511 がん患者の疼痛\n", "1 jRCT1032240506 卵巣がん\n", "2 jRCT1042240125 膵嚢胞、慢性膵炎、家族性膵がん及び遺伝性膵がん家族歴を有する症例、糖尿病症例(新規発症・急性...\n", "3 jRCT1052240186 肺がん\n", "4 jRCT1030240477 固形がん\n", ".. ... ...\n", "231 jRCT2080224549 進行性悪性黒色腫\n", "232 jRCTs051180046 乳がん\n", "233 jRCT2091220364 ALK遺伝子異常を有する希少がん\n", "234 jRCT2080223823 Part1:固形がん\\nPart2:頭頸部がん,尿路上皮がん\n", "235 jRCT1090220224 下腹部消化器がん \n", "\n", "[236 rows x 2 columns]" ] }, "execution_count": 12, "metadata": {}, "output_type": "execute_result" } ], "source": [ "targetdf" ] }, { "cell_type": "code", "execution_count": null, "metadata": {}, "outputs": [], "source": [] } ], "metadata": { "kernelspec": { "display_name": "gradio", "language": "python", "name": "python3" }, "language_info": { "codemirror_mode": { "name": "ipython", "version": 3 }, "file_extension": ".py", "mimetype": "text/x-python", "name": "python", "nbconvert_exporter": "python", "pygments_lexer": "ipython3", "version": "3.12.3" } }, "nbformat": 4, "nbformat_minor": 2 }